Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ALPMY

Astellas Pharma (PK) (ALPMY)

Astellas Pharma Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ALPMY
DateTimeSourceHeadlineSymbolCompany
16/12/202309:53Dow Jones NewsMerck, Pfizer, Astellas Get FDA OK For Expanded Use Of Keytruda Plus PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
01/12/202310:04Dow Jones NewsAstellas, Seagen: Cancer Treatment Padcev Supplemental Biologics License Application Gets FDA Priority ReviewUSOTC:ALPMYAstellas Pharma Inc (PK)
22/09/202321:02Dow Jones NewsMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits EndpointsUSOTC:ALPMYAstellas Pharma Inc (PK)
08/08/202300:41Dow Jones NewsPoseida Therapeutics Shares Leap on Astellas InvestmentsUSOTC:ALPMYAstellas Pharma Inc (PK)
07/08/202323:58Dow Jones NewsPoseida Therapeutics in $50 Million Investment Deal With AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
01/05/202310:57Dow Jones NewsAstellas Pharma to Buy Iveric Bio for About $5.9 BillionUSOTC:ALPMYAstellas Pharma Inc (PK)
10/01/202302:49Dow Jones NewsSelecta Biosciences Shares Rise 11% After Licensing Deal With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
25/10/202221:26Dow Jones NewsTaysha Gene Therapies Shares Soar Premarket on Astellas InvestmentUSOTC:ALPMYAstellas Pharma Inc (PK)
29/06/202200:28Dow Jones NewsSutro Biopharma Shares Rise 24% After Collaboration With Astellas PharmaUSOTC:ALPMYAstellas Pharma Inc (PK)
28/06/202210:37Dow Jones NewsSutro Biopharma Shares Soar 67% on Cancer Treatment Collaboration with AstellasUSOTC:ALPMYAstellas Pharma Inc (PK)
14/04/202202:31Dow Jones NewsEuropean Commission Approves Drug for Urothelial CancerUSOTC:ALPMYAstellas Pharma Inc (PK)
17/12/202123:37Dow Jones NewsAstellas Pharma, Seagen Get CHMP Positive Opinion for PadcevUSOTC:ALPMYAstellas Pharma Inc (PK)
11/08/202121:54Dow Jones NewsFDA Rejects FibroGen's Roxadustat for Anemia of Chronic Kidney DiseaseUSOTC:ALPMYAstellas Pharma Inc (PK)
22/12/201708:17Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:ALPMYAstellas Pharma Inc (PK)
30/09/201703:03Edgar (US Regulatory)Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)USOTC:ALPMYAstellas Pharma Inc (PK)
22/08/201622:50Dow Jones NewsPfizer Adds Key Cancer Drug in $14 Billion Biotech DealUSOTC:ALPMYAstellas Pharma Inc (PK)
09/07/201617:02Dow Jones NewsCorrections & Amplifications -- WSJUSOTC:ALPMYAstellas Pharma Inc (PK)
07/07/201615:20Dow Jones NewsTest Aids Prostate Cancer TreatmentUSOTC:ALPMYAstellas Pharma Inc (PK)
02/06/201608:40Dow Jones NewsSanofi Asks for Record Date for Vote on Medivation's BoardUSOTC:ALPMYAstellas Pharma Inc (PK)
29/04/201608:10Dow Jones NewsDrugmakers Place Big Bets on Cancer MedicinesUSOTC:ALPMYAstellas Pharma Inc (PK)
30/03/201601:50Dow Jones NewsLawmakers Target Medivation Over Drug PricesUSOTC:ALPMYAstellas Pharma Inc (PK)
05/12/201508:03The Motley FoolOcata Therapeutics Almost Doubled in November -- Here's WhyUSOTC:ALPMYAstellas Pharma Inc (PK)
26/11/201501:04The Motley FoolJohnson & Johnson's Latest FDA Approval Could Spell Problems for AmgenUSOTC:ALPMYAstellas Pharma Inc (PK)
24/11/201502:07The Motley Fool3 Value Stocks Near 52-Week Lows Worth BuyingUSOTC:ALPMYAstellas Pharma Inc (PK)
07/11/201504:40The Motley FoolMedivation Inc is Down Today -- But Why?USOTC:ALPMYAstellas Pharma Inc (PK)
02/11/201523:34The Motley Fool3 Stocks to Buy Now in BiotechUSOTC:ALPMYAstellas Pharma Inc (PK)
16/07/201504:33Dow Jones NewsAsian Shares: China Stocks Tumble as Investors Doubt Beijing's HelpUSOTC:ALPMYAstellas Pharma Inc. ADR
22/03/201522:01The Motley FoolBest One-Drug Wonder Stock for 2015USOTC:ALPMYAstellas Pharma Inc (PK)
30/01/201515:30Dow Jones NewsValeant to Buy Prostate-Cancer Drug From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
30/01/201515:10Dow Jones NewsValeant in Deal to Buy Prostate-Cancer Drug Provenge From DendreonUSOTC:ALPMYAstellas Pharma Inc. ADS
 Showing the most relevant articles for your search:USOTC:ALPMY